A few studies have suggested that bladder cancer cells could initiate an immune response by presenting antigen to CD4 T cells [25,26,27,28,29]; however, the ability to effectively present antigen and activate CD4 T cells is generally limited to professional antigen presenting cells. The gene discussed is CD4; the disease is urinary bladder cancer.